Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-571-6 | CAS number: 108-31-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1983-03-14 to 1983-06-02
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1983
- Reference Type:
- review article or handbook
- Title:
- Maleic Anhydride and Maleic Acid, SIDS Initial Assessment Report For SIAM 18
- Author:
- OECD SIDS
- Year:
- 2 004
- Bibliographic source:
- OECD SIDS Initial Assessment Report For SIAM 18, Paris, France, 20-23 April 2004
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- (positive controls were not used, only 50 cells per animal were analyzed)
- GLP compliance:
- no
- Type of assay:
- chromosome aberration assay
Test material
- Reference substance name:
- Maleic anhydride
- EC Number:
- 203-571-6
- EC Name:
- Maleic anhydride
- Cas Number:
- 108-31-6
- Molecular formula:
- C4H2O3
- IUPAC Name:
- 2,5-dihydrofuran-2,5-dione
- Details on test material:
- - Name of test material (as cited in study report): Maleic anhydride
- Physical state: crystalline briquettes
- Analytical purity: 100% active ingredient was assumed
- Stability under test conditions: Under the conditions of the assay, the compound was assumed to be stable.
- Storage condition of test material: room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Remarks:
- albino
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River
- Housing: individually
- Diet: ad libitum (except during the exposure period)
- Water: ad libitum (except during the exposure period)
- Acclimation period: 19 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-27
- Humidity (%): 32-66
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- inhalation
- Vehicle:
- - Vehicle(s)/solvent(s) used: none
- Details on exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Atmospheres were generated by heating maleic anhydride in flasks and transporting the vapors with nitrogen gas to 5 m³ glass and stainless steel chambers.
- Temperature, humidity in air chamber: 23-25°C, 36-45%
- Air flow rate: 1 L/min
TEST ATMOSPHERE
- Brief description of analytical method used: Atmospheric concentrations were monitored five times during the exposure period with two methods: 1. chamber samples were bubbled through distilled water and maleic acid was determined by a HPLC method; 2. chamber samples were drawn through a glass tube filled with p-Anisidine coated with XAD-resin beads, and the maleic anhydride derivative was determined by HPLC (methods provide a measure of total maleic (maleic acid plus maleic anhydride converted to maleic acid) and maleic anhydride).
- Samples taken from breathing zone: yes (5 times in 6 hours) - Duration of treatment / exposure:
- 6 hrs
- Frequency of treatment:
- once
- Post exposure period:
- Sacrifice at 6, 24, and 48 hours.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/m³ air (nominal)
- Dose / conc.:
- 1 mg/m³ air (nominal)
- Remarks:
- analytical concentration range: 1.66 - 3.06 mg/m³; average concentration of 2.34 mg/m³.
- Dose / conc.:
- 100 mg/m³ air (nominal)
- Remarks:
- analytical concentration range: 20.43 - 49.29 mg/m³; average concentration of 33.30 mg/m³.
- No. of animals per sex per dose:
- 15
- Control animals:
- yes, concurrent no treatment
- Positive control(s):
- none
Examinations
- Tissues and cell types examined:
- Bone marrow cells were collected and processed for analysis.
- Details of tissue and slide preparation:
- SAMPLING TIMES: Five animals per sex per group were killed 6, 24 or 48 hours following termination of exposure.
DETAILS OF SLIDE PREPARATION: Bone marrow cells were removed by aspiration from both femurs of rat immediately after sacrifice. Subsequently, the cells were fixed, dropped on slides and stained. Two slides were prepared for each animal and analyzed by an individual who was unfamiliar with the animals identity. Generally, fifty cells in metaphase were examined from each rat that provided analyzable cells.
METHOD OF ANALYSIS: The following parameters were calculated for each animal: numbers and type of chromosomal aberrations, mitotic index, chromosome number, and vernier location each metaphase containing damage .
- Statistics:
- The mean mitotic indices, mean modal numbers, percent aberrant cells and the total number of aberrations per animal for each group were statistically compared using the Kruskal-Wallis nonparametric analysis of variance and nonparametric all pairwise group comparison.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Negative controls validity:
- valid
- Positive controls validity:
- not examined
- Additional information on results:
- No deaths occurred during the study but all treated animals were sluggish during exposure and many of the high-dose group had squinted eyes and bloody encrusted nose. One hour after exposure, all rats in the high dose group appeared sluggish and there was a bloody crust around the nose of four males and six females. No evidence of toxicity in the bone marrow cells were observed. There were no treatment-related effects on the frequency of chromosomal aberrations at any of the times examined. A statistically significant increase (p=0.022) in chromosome number was observed in the low-dose animals at 6 hours and in the high-dose animals at 24 hours (p=0.045); these were not considered treatment-related. None of the rats had polyploid or aneuploid cells and none had consistently abnormal chromosome numbers.
Applicant's summary and conclusion
- Conclusions:
- In this study, under the given conditions, maleic anhydride is not considered to be clastogenic at any of the dose levels tested.
- Executive summary:
In a Sprague-Dawley albino rats bone marrow chromosomal aberration assay (equivalent to OECD Guideline 475), 15 rats/sex/concentration were treated via inhalation route with maleic anhydride (100 % purity). at concentrations of 0, 1 or 100 mg/m³. Bone marrow cells were harvested at 6, 24- and 48-hours post-treatment.
There were signs of toxicity during the study. All treated animals were sluggish during exposure and many of the high-dose group had squinted eyes and bloody encrusted nose. One hour after exposure, all rats in the high dose group appeared sluggish and there was a bloody crust around the nose of four males and six females. However, no evidence of toxicity in the bone marrow cells were observed. There were no treatment-related effects on the frequency of chromosomal aberrations at any of the times examined. A statistically significant increase (p=0.022) in chromosome number was observed in the low-dose animals at 6 hours and in the high-dose animals at 24 hours (p=0.045); these were not considered treatment-related. None of the rats had polyploid or aneuploid cells and none had consistently abnormal chromosome numbers.
This study is classified as acceptable with some restrictions ( purity of the test substance was not known and positive controls were not used) and satisfies the requirement for Test Guideline OECD 475 for in vivo cytogenetic mutagenicity data.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
